Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $-5,530,000
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 52,300
- Avg volume
- 11,960
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- 4%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
- Phone
- (805) 699-5596
- Website
- https://phytanix.com
- Address
- 701 Anacapa Street, Suite C, Santa Barbara, United States
Latest news
No headlines yet.
